Display options
Share it on

Chonnam Med J. 2013 Apr;49(1):14-9. doi: 10.4068/cmj.2013.49.1.14. Epub 2013 Apr 25.

Comparison of Endoscopic Variceal Ligation and Endoscopic Variceal Obliteration in Patients with GOV1 Bleeding.

Chonnam medical journal

Hyoung Ju Hong, Chung Hwan Jun, Du Hyeon Lee, Eun Ae Cho, Seon Young Park, Sung Bum Cho, Chang Hwan Park, Young Eun Joo, Hyunsoo Kim, Sung Kyu Choi, Jong Sun Rew

Affiliations

  1. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

PMID: 23678472 PMCID: PMC3651981 DOI: 10.4068/cmj.2013.49.1.14

Abstract

The aim of this study was to compare the efficacy, rebleeding rates, survival, and complications of endoscopic variceal ligation (EVL) with those of endoscopic variceal obliteration (EVO) in patients with acute type 1 gastroesophageal variceal (GOV1) bleeding. Data were collected retrospectively at a single center. A total of 84 patients were selected (20 patients underwent EVL; 64 patients underwent EVO) from February 2004 to September 2011. Their clinical characteristics, laboratory results, vital signs, Child-Pugh score, Model for End-stage Liver Disease (MELD) score, and overall mortality were evaluated. There were no significant differences in baseline characteristics between the two groups. The success rate in initial control of active bleeding was not significantly different between the EVL and EVO groups (18/20 EVL, or 90.0%, compared with 62/64 EVO, or 96.9%; p=0.239). The early rebleeding rate was also not significantly different between the groups (3/18 EVL, or 16.7% compared with 17/62 EVO, or 27.4%; p=0.422). The late rebleeding rate of the EVL group was lower than that of the EVO group (3/18 EVL, or 16.7%, compared with 26/59 EVO, or 44.1%; p=0.042). The time-to-rebleeding was 594 days for the EVL group and 326 days for the EVO group (p=0.054). In the multivariate analysis, portal vein thrombosis (PVT) was a significant risk factor for early rebleeding. Hepatocellular carcinoma (HCC) and previous history of bleeding were significant risk factors for very late rebleeding. In conclusion, EVL is better than EVO in reducing late rebleeding in acute GOV1 bleeding. HCC, PVT, and previous bleeding history were significant risk factors for rebleeding.

Keywords: Endoscopy; Esophageal and gastric varices; Hemostasis; Risk factors

References

  1. Gastroenterology. 1988 Aug;95(2):434-40 - PubMed
  2. J Am Soc Echocardiogr. 1995 Sep-Oct;8(5 Pt 1):759-61 - PubMed
  3. J Korean Med Sci. 2006 Oct;21(5):883-90 - PubMed
  4. Gastrointest Endosc. 2005 Nov;62(5):651-5 - PubMed
  5. Am J Gastroenterol. 2003 Dec;98(12):2688-93 - PubMed
  6. Med Clin North Am. 2008 May;92(3):551-74, viii - PubMed
  7. Am J Gastroenterol. 2002 Apr;97(4):1010-5 - PubMed
  8. Hepatology. 2006 Apr;43(4):690-7 - PubMed
  9. Endoscopy. 2005 Jul;37(7):667-73 - PubMed
  10. Hepatology. 1992 Dec;16(6):1343-9 - PubMed
  11. Hepatology. 2001 May;33(5):1060-4 - PubMed
  12. Endoscopy. 1994 Mar;26(3):287-91 - PubMed
  13. Semin Liver Dis. 2002 Feb;22(1):73-82 - PubMed
  14. Hepatology. 1989 Oct;10(4):488-93 - PubMed
  15. Nat Clin Pract Gastroenterol Hepatol. 2005 Nov;2(11):526-35 - PubMed
  16. Gastroenterology. 2004 Apr;126(4):1175-89 - PubMed
  17. J Hepatol. 2010 Oct;53(4):762-8 - PubMed
  18. Hepatology. 2007 Sep;46(3):922-38 - PubMed
  19. Korean J Hepatol. 2012 Mar;18(1):1-21 - PubMed
  20. Am J Gastroenterol. 1996 Oct;91(10):2103-9 - PubMed
  21. Gastrointest Endosc. 1981 Nov;27(4):213-8 - PubMed
  22. Gastroenterol Clin North Am. 1992 Mar;21(1):85-101 - PubMed

Publication Types